Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses Tácio de Mendonça LimaMarília Berlofa VisacriPatricia Melo Aguiar Review 27 October 2021 Pages: 311 - 338
Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials Beatriz Monteiro FernandesEstêvão Scotti-MuzziMárcio Gerhardt Soeiro-de-Souza Review 27 October 2021 Pages: 339 - 349
Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies Bhavani Shankara BagepallyAkhil Sasidharan Review 27 October 2021 Pages: 351 - 363
Use of acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies Jiang YangTing-jie ZhouDan-ni Bao Review 27 October 2021 Pages: 365 - 373
No association between acid suppressant use and risk of dementia: an updated meta-analysis Hengmin WangLiang TianXiaohong Yan Review 22 November 2021 Pages: 375 - 382
Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis Hong-Bae KimJung-Ha KimBethany J. Wolf Review 24 November 2021 Pages: 383 - 391
Evaluation of serum levels of asprosin and other metabolic profiles in patients with idiopathic tonic–clonic generalized epilepsy on treatment with valproic acid Amir-mohammad YaryariMehrdokht MazdehMaryam Mehrpooya Pharmacodynamics 20 January 2022 Pages: 393 - 403
Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder Yan-Nan ZangWei GuoCan-Jun Ruan Pharmacokinetics and Disposition 02 December 2021 Pages: 405 - 418
Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances Maximilian GahrBernhard J. ConnemannAlmuth Wolf Pharmacoepidemiology and Prescription Open access 27 October 2021 Pages: 419 - 434
Hospitalizations and deaths related to adverse drug events worldwide: Systematic review of studies with national coverage Lunara Teles SilvaAna Carolina Figueiredo ModestoFlavio Marques Lopes Pharmacoepidemiology and Prescription 30 October 2021 Pages: 435 - 466
Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults Zhen ZhouAndrea J. CurtisMark R. Nelson Pharmacoepidemiology and Prescription 26 October 2021 Pages: 467 - 476
Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries Jonas KindstedtMaria SjölanderMaria Gustafsson Pharmacoepidemiology and Prescription Open access 04 November 2021 Pages: 477 - 487
Trends and variation in benzodiazepine use in nursing homes in the USA Ioannis MalagarisHemalkumar B. MehtaJames S. Goodwin Pharmacoepidemiology and Prescription 02 November 2021 Pages: 489 - 496
Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study Luis A. García RodríguezLucía Cea SorianoDavid Gaist Pharmacoepidemiology and Prescription Open access 17 November 2021 Pages: 497 - 504
The effect of preoperative statin treatment on acute kidney injury in elderly patients undergoing valve replacement surgery Bing-qi FuXue-biao WeiDan-qing Yu Pharmacoepidemiology and Prescription 23 November 2021 Pages: 505 - 512
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy Sanna ValliusHeidi TaipaleMiia Tiihonen Pharmacoepidemiology and Prescription Open access 27 November 2021 Pages: 513 - 521
Placebo control group in COVID-19 vaccine trials: context and timing matters Rafael Dal-Ré Point of View 27 November 2021 Pages: 523 - 526
Severe acyclovir-induced encephalopathy in an elderly patient with herpes zoster Kota NakajimaKenji MomoTadanori Sasaki Letter to the Editor 29 October 2021 Pages: 527 - 529
